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There have been many attempts to detect circulating cells from solid malignant tumours in peripheral blood. Many malignant tumours spread via the bloodstream and, while the number of such cells thought to be present is relatively small, it is these cells that will be a major factor in determining the patients' final outcome. The detection of such cells is potentially important, both clinically, as presumably their presence would be an adverse prognostic factor, and scientifically, as it would allow the isolation, and subsequent study, of such cells by fractionation procedures.
Early attempts used microscopy to examine the cells retained on 'sieves' after filtration of blood samples (Goldblatt and Nadel, 1965; McGrew, 1965; Seal, 1964; Stanford, 1971) . However, these techniques were unreliable owing to the difficulties of differentiating tumour cells from other retained cell types, and these techniques have now been abandoned. An immunocytochemical technique has been described for the detection of micrometastases for breast car- cinoma in bone marrow aspirates (Redding et al., 1983) and for neuroblastoma cells in penpheral blood (Moss and Sanders, 1990 (McLean et al., 1977 (McLean et al., , 1982 Shammas and Blodi, 1977) despite the fact that only 1% of patients show evidence of metastases at presentation (Char, 1978) . Fraunfelder et al. (1977) suggested that surgery could provoke metastatic spread, and this was followed by the proposal that two-thirds of metastatic disease is attributable to surgical manipulation of the globe during enucleation for uveal melanoma (Zimmerman et al., 1978; 7immerman and McLean, 1979; McLean et al., 1982 magnesium chloride and 1 x PCR buffer) containing 12.5 pmol of each of the primers 5'-GAGCACAGAGCCTC-GCCTTTGC-3' and 5'-GGATCITCATGAGGTAGTCA-GTCAGG-3' (which are specific for -actin cDNA) followed by amplificaton (96C for 3 min then 30 cycles of 60 C for 45 s, 72C for 30 s and 94C for 60 s) to give a 620 bp product.
The positive control for the PCR was the plasmid PmeL34 (Kwon et al., 1987) , which contais the tyrosinase cDNA sequence and which had been linearised by digestion with EcoRI.
Each PCR run contained at least three negative controls, including a pipette negative control (after adding the positive control, the tip of the pipette was changed and a dummy pipetting action performed in a negative control). In addition to the PCR negative controls, at least one RNA extraction RT-PCR and one RT-PCR negative control were processed with each run.
Several general measures were employed to reduce the risk of false positives from either plasmid or carry-over contamination from previously amplified product. The RNA extraction was performed in a separate room in a class 2 containment hood using new pipettes with aerosol-resistant pipette tips which had never been used for DNA work. The RT and PCR set-up steps were also done in a separate room in a class 2 containmnt hood with the operator gloved and gowned with the gowns and clothing washed between experiments and the pipettes iradiated with UVB in the Ampirad for 1 h (30 min each side). The template from the RT step and the plasmid positive controls were added to the room in a third reaction mix in a third room in a third class 2 containment hood and the PCR machine was kept in a fourth room with the gel ekctrophoretic tankrs. After the gels had been run and photographed, the gels, samples and running buffer were all discarded into an autoclave bag and autoclaved and the gel tanks and all work surfaces leaned between experiments. The RT and PCR set-ups Figure 1 ). This is good evidence for the nested PCR being capable of detecting one molecule of tyrosinase cDNA in the PCR reaction mix.
With such a sensitive technique, false positives due to carry-over contamination from previously amplified product can be a problem. Thirty-one RNA extraction RT-PCR, 12 RT-PCR and 72 PCR negative controls were run. There were two false positives, both in the RNA extraction RT-PCR negative control group (discussed below).
The sensitivity of the technique was checked on 3.2 ml blood samples spiked with melanoma cells. Three melanoma cell lines were used and four primary uveal melanoma cell cultures. Blood samples were spiked in two different ways. An inverting microscope and micropipette and manipulators were used to transfer single cells. This technique has two disadvantages. It is not possible to assess the viability of transferred cells and there is room for marked operator selection bias (which could work in either direction) in the choice of the cell transferred, which may not be representative of the cell suspension. A second technique is to count viable cells (as assessed by trypan blue exclusion) with a haemocytometer and then to dilute and transfer an appropriate volume. The problem with this is the difficulty in achieving even mixing of the cell suspension (cells tend to settle) and marked inaccuracy at low-level dilutions. Both techniques gave similar answers with a best sensitivity of one cell per ml of blood (see Table I and Figure 2 ).
This sensitivity was less than that achieved by extracting RNA and RT from I04 cells from SK-Mel-23 and from SK-Mel-19 and diluting the RT mixture, when it proved possible to detect 0.01 and 0.1 of a cell respectively (consistent with tyrosinase mRNA being a middle abundance mRNA species with an estimated 100 molecules per cell). The reduced sensitivity with respect to whole blood is probably due to saturation of the RT step with 'excess' RNA. No reduction in the PCR sensitivity was noted when the plasmidpositive control was spiked into cDNA from negative control blood.
There were two positive reactions in the first 17 patients analysed, one from a negative control and alone from the an orbital recurrence 9 years after local resection of an epithelioid cell uveal melanoma (the recurrence was subsequently proven by biopsy). The 35 intraocular uveal melanoma patients consisd of 18 men and 17 women whose ages ranged from 23 to 86 years (mean age 64 years) and whose tumours ranged in height from 2.0 to 15 mm (mean 7.7 mm and median 7.2 mm) and the LTD ranged from 7 to 20 mm (mean 13 mm and median 12mm). Twenty-eight of the tumours were pigmented, five were lightly pigmented and two were alanotic. Fifteen patients had second samples taken, and these were also negative.
The P-actin RT-PCR positive controls gave strong signals in all cases, thus both RNA preparation and cDNA synthesis were successful. In addition, amplification of tyrosinase sequences from plasmid performed on the three dilutions described above showed that the PCR plication steps also worked and we conclude that the negative results were not due to any technical problems.
As we were unable to find circulating melanoma cells in patients with primary disease, we tested six patients (two men and four women) with advanced metastatic cutaneous melanoma (who had not received chemotherapy), and they too were all negative. RNA extraction yield was checked by optical density readings (which were satisfactory at 30-60 g per 3 ml blood sample) and integrity by demonstating 285 and 185 rRNA bands on denaturing RNA ges, in additon to successful am aon of P-actin cDNA in RT-PCR reactions.
Results on perioperatve blood sanples It has been suggested that surgial procedures can provoke metastatic spread of ocular melanoma. Perioperative blood samples were taken from 20 procedures: 11 enucleations, four insertions of radioactive plaques (brachytherapy), four insertions of tantalum markers (as a prelude for proton beam radiotherapy) and two trapdoor intraocular biopsies (one combined with insertion of tantalum markers). The blood was taken at the end of surgery for all the procedures with the exception of enucleations, when the blood sample was taken at the time the optic nerve was cut. All these samples were also negative; again RNA isolation, cDNA synthesis and PCR controls gave clear signals.
There were no positive results in 51 samples from 36 patients with active uveal melanoma and none in six samples from six patients with advanced metastatic cutaneous melanoma. The two positive results were in a control patient (with acute glaucoma) and in a patient with a suspicious choroidal naevus, and both of these have been treated as false positives. The probable origin of these false positives is contamination of the samples by cutaneous melanocytes. These two false positives occurred early in the study and there were no more postives following a change in protocol for blood smpling. The resolution of the technique is good and can detect down to one melanoma cell per ml of blood. This includes two cases where we cultured cells from the melanoma and showed that we could detect those cells spiked into blood samples but not in that patient's blood. These findings are in contrast to the two previous studies (Smith et al., 1991; Tobal et al., 1993) . In our pilot study (Tobal et al., 1993) , it appeared to be possble to detect two VUP cells per ml of bklo, but we have been unable to repeat this, and our sensitivity for this cell line is >10' VUP cellsml-'. Thr is often a short 'honeymoon' period in performing such sensitive PCR while there is a build-up of product before carry-over contamination becomes a probkm, arising both from setting up the PCR and collection and handling of the sample, RNA extraction and RT steps. Carry-over of one moklcule (which corresponds to 10-'jl of a positive reaction product) is sufficient for a false-positive reaction. It is probable that this honeymoon period was shorter than realised and that the results are expliable by unrecognised carry-over contamination. Following completion of the pilot study, we had sigifiant technical problems with false postives which took 12 months to overcome. A similar explanation may apply to the first study (Smith et al., 1991) .
The problem of contamination causing false positives in PCR-based assays is well recognised (Lo et al., 1989; Sarkar and Sommer, 1990) . The difficulty of genrating negative controls using RT-PCR led Chelly et al. (1989) to propose the concept of ilklgitimate transcription, namely that any cell would produce transcripts from any gene and s d exploiting this to get supposedly tissue-s transcripts by using RT-PCR on peripheral blood. The present study is strong evidenc against ilgitimate transcription for tyrosinase in peripheral blood.
An explanation for our negative findings would be that we are looking in the wrong place. Blood from the eye would have to pass both the pulmonary and a systemic capillary bed before reaching a peripheral vein. There is evidence, however, that melanoma cells can successfully traverse capillary beds and that many organs have relatively large arteriovenous anastomoses of 100-400 pm (Prinzmetal et al., 1948; Tobin and Zariquiey, 1950) . Moreover, this objection should not apply in the cases of the patients with advanced metastatic cutaneous melanoma.
The positive controls worked well and suggest that there is kss than one melanoma cell per ml of blood in the circulation of paients with melanoma -even in those with advanced disease. One cell per ml of blood would still correspond to a total of 4 500 crculating cells (for a typical blood volume of 4.5 1). Fifty-seven samples would be expected to have an occasional positive if more than 45 circulating cells are present at any one time. Clearly, the sing of only one cell would be theoretically sufficient for the establishment of a metastatic deposit and that sheding could be intermittent. The most likely explanation is that there are far fewer circulating malignant cells than commonly supposed in these patients. It is probable that any other technique that looks for single metastatic cells in peripheral blood will prove to be no more successful.
The failure to find circulating melanoma cells during surgical procedures such as enucleation argues against surgery as being the cause of subsequent metastatic disease. Uveal melanomas are relatively slow growing, and it is thought that it takes several years to reach a size which would necesstate enucleation (McLean et al., 1980) . If two-thirds of metastatic deposits are the result of surgically triggered spread [and assuming that the tumour has been present for 5 years (McLean et al., 1980) and that it takes about 20 min to remove an eyel then the re4uired hing rate must be increased by 10' during the period of the surgery, and this should have been detectable. Therefore, it is unlikely that surgery causes any significant increase in melanoma cell shedding. There is other evidence for this. There is no difference in overall survival between different treatment options [enucleation vs brachytherapy (Augsburger et al., 1990 ) vs proton beam radiotherapy (Seddon et al., 1990 ) vs local resection (Foulds et al., 1987] . Further preoperative radiotherapy (Bornfeld et al., 1989) , before enucleation, does not improve overall survival. This is the first large series reporting the use of RT-PCR in the detection of ciculating metastatic cells from melanoma tumours and, unfortunately, it would appear not to live up to its initial promise. The technique may be of more use in detecting metastatic cells in other tumours, paricularly neuroblastoma (Burchill et al., 1994 
